13F Data
13F filer · CIK 1802528

Fairmount Funds Management LLC

WEST CONSHOHOCKEN, PA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$1.5B
+$128.6M vs prior
Positions
12
New / sold out
1 / 1
Added / reduced
1 / 0
Turnover
2.7%
buys $39.7M · sells $202.7M
Top-10 weight
97.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedVIRIDIAN THERAPEUTICS INC+1,176,470+30.1%+$21.6M
NewFAETH THERAPEUTICS INC+722,020–+$18.1M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPYRE THERAPEUTICS INC-4,018,101-100.0%$-202.7M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $165.0MQ1 2020: $164.9MQ2 2020: $224.2MQ3 2020: $236.1MQ4 2020: $279.6MQ1 2021: $237.2MQ2 2021: $243.2MQ3 2021: $275.0MQ4 2021: $303.3MQ1 2022: $422.9MQ2 2022: $436.9MQ3 2022: $568.9MQ4 2022: $630.4MQ1 2023: $581.5MQ2 2023: $709.3MQ3 2023: $831.2MQ4 2023: $946.5MQ1 2024: $917.4MQ2 2024: $885.1MQ3 2024: $1.2BQ4 2024: $1.0BQ1 2025: $644.6MQ2 2025: $771.9MQ3 2025: $1.1BQ4 2025: $1.3BQ1 2026: $1.4BQ2 2026: $1.5B
Q4 2019Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ORUKA THERAPEUTICS INCCOM3,705,262$352.6M23.31%
2DIANTHUS THERAPEUTICS INCCOM2,537,191$247.3M16.35%
3DAMORA THERAPEUTICS INCCOM NEW8,713,000$226.6M14.98%
4COGENT BIOSCIENCES INCCOM5,503,418$213.0M14.08%
5JADE BIOSCIENCES INCCOM NEW4,553,494$101.2M6.69%
6ENLIVEN THERAPEUTICS INCCOM1,855,644$94.2M6.22%
7VIRIDIAN THERAPEUTICS INCCOM5,090,928$93.5M6.18%
8ZENAS BIOPHARMA INCCOM2,359,025$59.9M3.96%
9CRESCENT BIOPHARMA INC.COM2,747,866$49.5M3.27%
10APOGEE THERAPEUTICS INCCOM298,647$39.6M2.62%
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.